RxDoctor Payments Data
★ My doctorsLook up a doctor →

Savannah White

Medical · Charlotte, NCNPI 1154808525

Payments from drug & device makers

$3,193in general payments, 2019–2025

Across 155 payments — averaging $20.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$487
  • Johnson & Johnson$236
  • Merck$174
  • AstraZeneca$166
  • Bristol Myers Squibb$157
  • Astellas Pharma US Inc$153
  • plus $2K from 38 others

What the payments were for

  • Food & beverage$3,193100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis20$487
Johnson & Johnson(2 entities)10$236
Merck7$174
AstraZeneca(2 entities)9$166
Bristol Myers Squibb9$157
Astellas Pharma US Inc8$153
Sanofi4$108
GSK4$97
Seagen Inc.6$96
Pfizer5$94
EMD Serono, Inc.3$88
Lilly USA, LLC4$85
G1 Therapeutics, Inc.3$80
Genentech USA, Inc.5$79
Bayer5$79
Genmab U.S., Inc.3$67
Takeda Pharmaceuticals U.S.A., Inc.2$64
Daiichi Sankyo Inc.2$57
Incyte Corporation3$55
Karyopharm Therapeutics Inc.3$55
AVEO Pharmaceuticals, Inc.3$51
Jazz Pharmaceuticals Inc.3$50
Taiho Oncology, Inc.3$47
Servier Pharmaceuticals LLC2$46
Puma Biotechnology, Inc.2$44
Mirati Therapeutics, Inc.2$43
Deciphera Pharmaceuticals Inc.1$41
AbbVie2$39
Beigene USA, Inc.2$33
Rigel Pharmaceuticals, Inc.2$32
Morphosys, US Inc.2$29
Exelixis Inc.2$28
CTI Biopharma Corp.2$27
Blueprint Medicines Corporation2$26
Eisai Inc.1$23
Regeneron Healthcare Solutions, Inc.1$22
Ipsen Biopharmaceuticals, Inc1$20
Gilead1$19
Sumitomo Pharma America, Inc.1$18
Epizyme, Inc.1$17
Myovant Sciences Inc.1$17
E.r. Squibb & Sons, L.L.C.1$15
ADC Therapeutics America, Inc.1$14
Helsinn Therapeutics (U.S.), Inc.1$14

How this compares

$3,193 in reported general payments places this provider in the 80th percentile of 878 medical providers in North Carolina.

See all medical providers in North Carolina →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Anastrozole17$504

Paid to pharmacies, not to this prescriber.

Other medical in Charlotte

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →